-
公开(公告)号:US09708313B2
公开(公告)日:2017-07-18
申请号:US14883174
申请日:2015-10-14
申请人: Jason W. Brown , Stephen Hitchcock , Maria Hopkins , Shota Kikuchi , Holger Monenschein , Holly Reichard , Kristin Schleicher , Huikai Sun , Todd Macklin
发明人: Jason W. Brown , Stephen Hitchcock , Maria Hopkins , Shota Kikuchi , Holger Monenschein , Holly Reichard , Kristin Schleicher , Huikai Sun , Todd Macklin
IPC分类号: C07D241/38 , C07D471/04
CPC分类号: C07D471/04
摘要: This present invention provides compounds of formula II: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.
-
公开(公告)号:US20170174677A1
公开(公告)日:2017-06-22
申请号:US15118447
申请日:2015-02-13
申请人: Stephen Hitchcock , Maria Hopkins , Shota Kikuchi , Holger Monenschein , Holly Reichard , Huikai Sun , Todd Macklin
发明人: Stephen Hitchcock , Maria Hopkins , Shota Kikuchi , Holger Monenschein , Holly Reichard , Huikai Sun , Todd Macklin
IPC分类号: C07D471/04
CPC分类号: C07D471/04
摘要: The present invention provides compounds of formula I: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.
-
公开(公告)号:US09346829B2
公开(公告)日:2016-05-24
申请号:US14645639
申请日:2015-03-12
申请人: Stephen Hitchcock , Holger Monenschein , Holly Reichard , Huikai Sun , Shota Kikuchi , Todd Macklin , Maria Hopkins
发明人: Stephen Hitchcock , Holger Monenschein , Holly Reichard , Huikai Sun , Shota Kikuchi , Todd Macklin , Maria Hopkins
IPC分类号: A61K31/19 , A61K31/5386 , C07D519/00 , C07D498/08 , C07D451/12 , C07D471/04 , C07D221/22
CPC分类号: C07D498/08 , A61K31/19 , A61K31/5386 , C07C53/18 , C07C53/40 , C07D221/22 , C07D451/12 , C07D453/02 , C07D471/04 , C07D471/08 , C07D519/00
摘要: The present invention provides a method of treating nicotine addiction comprising administering a 5-HT3 receptor antagonists of Formula (I):
摘要翻译: 本发明提供了一种治疗尼古丁成瘾的方法,包括给予式(I)的5-HT 3受体拮抗剂:
-
公开(公告)号:US20160031881A1
公开(公告)日:2016-02-04
申请号:US14883174
申请日:2015-10-14
申请人: Jason W. Brown , Stephen Hitchcock , Maria Hopkins , Shota Kikuchi , Holger Monenschein , Holly Reichard , Kristin Schleicher , Huikai Sun , Todd Macklin
发明人: Jason W. Brown , Stephen Hitchcock , Maria Hopkins , Shota Kikuchi , Holger Monenschein , Holly Reichard , Kristin Schleicher , Huikai Sun , Todd Macklin
IPC分类号: C07D471/04
CPC分类号: C07D471/04
摘要: The present invention provides compounds of formula I: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.
摘要翻译: 本发明提供式I化合物:其可用作GPR6的调节剂,其药物组合物,用于治疗与GPR6相关的病症的方法,用于制备化合物的方法及其中间体。
-
公开(公告)号:US20150182533A1
公开(公告)日:2015-07-02
申请号:US14645639
申请日:2015-03-12
申请人: Stephen Hitchcock , Holger Monenschein , Holly Reichard , Huikai Sun , Shota Kikuchi , Todd Macklin , Maria Hopkins
发明人: Stephen Hitchcock , Holger Monenschein , Holly Reichard , Huikai Sun , Shota Kikuchi , Todd Macklin , Maria Hopkins
IPC分类号: A61K31/5386 , A61K31/19
CPC分类号: C07D498/08 , A61K31/19 , A61K31/5386 , C07C53/18 , C07C53/40 , C07D221/22 , C07D451/12 , C07D453/02 , C07D471/04 , C07D471/08 , C07D519/00
摘要: The present invention provides a method of treating nicotine addiction comprising administering a 5-HT3 receptor antagonists of Formula (I):
摘要翻译: 本发明提供了一种治疗尼古丁成瘾的方法,包括给予式(I)的5-HT 3受体拮抗剂:
-
公开(公告)号:US20170174659A1
公开(公告)日:2017-06-22
申请号:US15118461
申请日:2015-02-13
申请人: Mark E. Adams , Jason W. Brown , Stephen Hitchcock , Maria Hopkins , Shota Kikuchi , Betty Lam , Holger Monenschein , Holly Reichard , Huikai Sun
发明人: Mark E. Adams , Jason W. Brown , Stephen Hitchcock , Maria Hopkins , Shota Kikuchi , Betty Lam , Holger Monenschein , Holly Reichard , Huikai Sun
IPC分类号: C07D401/14 , C07D401/04 , C07D241/28
CPC分类号: C07D401/14 , C07D241/26 , C07D241/28 , C07D401/04
摘要: The present invention provides compounds of formula I: which are useful as modulators of GPR6, pharmaceutical compositions thereof, methods for treatment of conditions associated with GPR6, processes for making the compounds and intermediates thereof.
-
-
-
-
-